Characterization of myeloid neoplasms following allogeneic hematopoietic cell transplantation

We compared characteristics of myeloid neoplasms (MNs) following allogeneic hematopoietic cell transplantation (HCT) versus autologous HCT using a Japanese HCT registry database. Among 43 788 patients who underwent allogeneic (n = 18 874) or autologous HCT (n = 24 914) for non‐myeloid malignancies o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of hematology 2022-02, Vol.97 (2), p.185-193
Hauptverfasser: Kuno, Masatomo, Yamasaki, Satoshi, Fujii, Nobuharu, Ishida, Yasushi, Fukuda, Takahiro, Kataoka, Keisuke, Uchida, Naoyuki, Katayama, Yuta, Sato, Maho, Onai, Daishi, Miyamoto, Toshihiro, Ota, Shuichi, Yoshioka, Satoshi, Ara, Takahide, Hangaishi, Akira, Hashii, Yoshiko, Onizuka, Makoto, Ichinohe, Tatsuo, Atsuta, Yoshiko, Inamoto, Yoshihiro
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:We compared characteristics of myeloid neoplasms (MNs) following allogeneic hematopoietic cell transplantation (HCT) versus autologous HCT using a Japanese HCT registry database. Among 43 788 patients who underwent allogeneic (n = 18 874) or autologous HCT (n = 24 914) for non‐myeloid malignancies or non‐malignant diseases, 352 developed MNs. The cumulative incidence of MNs was lower after allogeneic HCT than after autologous HCT (0.3% vs. 1.8% at 10 years, respectively, p 
ISSN:0361-8609
1096-8652
DOI:10.1002/ajh.26401